Feed IPHA
IP
Innate Pharma S.A.
IPHA · NASDAQ
$1.78 +0.00% (+$0.00)
1M -7.41%
Market Cap 146.0M €
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$162.77
9070.1% upside
Current Price
$1.78
Undervalued Fair Value Overvalued
Valuation
0 /100
Expensive P/S 52.40x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 63.58%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 0.00%
Op. margin 0.00%
Quality
0 /100
Poor ROIC 0.00%
ROA 0.00%
Asset turnover 0.04x
Debt
59 /100
Moderate Current ratio 1.27x
Int. coverage -110.77x
Net debt/EBITDA 0.13x
Stability
26 /100
Unstable Beta 0.88x
Rev. volatility 38.58%
EPS volatility 364.59%
Ask StockBot about IPHA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jonathan E. Dickinson
Employees
163
Headquarters
Marseille
Upcoming events
17 SEP
Earnings
Upcoming earnings report